173 related articles for article (PubMed ID: 17056255)
1. AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.
Wojcik S; Engel WK; McFerrin J; Paciello O; Askanas V
Neuromuscul Disord; 2006 Dec; 16(12):839-44. PubMed ID: 17056255
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.
Fratta P; Engel WK; McFerrin J; Davies KJ; Lin SW; Askanas V
Am J Pathol; 2005 Aug; 167(2):517-26. PubMed ID: 16049336
[TBL] [Abstract][Full Text] [Related]
3. In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis.
Terracciano C; Nogalska A; Engel WK; Askanas V
J Neurochem; 2010 Jan; 112(2):389-96. PubMed ID: 19878439
[TBL] [Abstract][Full Text] [Related]
4. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.
Wojcik S; Engel WK; Yan R; McFerrin J; Askanas V
Acta Neuropathol; 2007 Nov; 114(5):517-26. PubMed ID: 17764014
[TBL] [Abstract][Full Text] [Related]
5. Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers.
Paciello O; Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Myol; 2006 Jun; 25(1):13-22. PubMed ID: 17039976
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
8. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers.
Nogalska A; Engel WK; McFerrin J; Kokame K; Komano H; Askanas V
J Neurochem; 2006 Mar; 96(5):1491-9. PubMed ID: 16441512
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle.
Vattemi G; Engel WK; McFerrin J; Askanas V
Am J Pathol; 2004 Jan; 164(1):1-7. PubMed ID: 14695312
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
12. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis.
Banwell BL; Engel AG
Neurology; 2000 Mar; 54(5):1033-41. PubMed ID: 10720271
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
14. Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.
Luo YB; Johnsen RD; Griffiths L; Needham M; Fabian VA; Fletcher S; Wilton SD; Mastaglia FL
Int J Exp Pathol; 2013 Dec; 94(6):418-25. PubMed ID: 24205796
[TBL] [Abstract][Full Text] [Related]
15. Activation of the γ-secretase complex and presence of γ-secretase-activating protein may contribute to Aβ42 production in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Askanas V
Neurobiol Dis; 2012 Oct; 48(1):141-9. PubMed ID: 22750528
[TBL] [Abstract][Full Text] [Related]
16. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
18. Increased BACE1 mRNA and noncoding BACE1-antisense transcript in sporadic inclusion-body myositis muscle fibers--possibly caused by endoplasmic reticulum stress.
Nogalska A; Engel WK; Askanas V
Neurosci Lett; 2010 May; 474(3):140-143. PubMed ID: 20236612
[TBL] [Abstract][Full Text] [Related]
19. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
[TBL] [Abstract][Full Text] [Related]
20. Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Acta Neuropathol; 2013 Nov; 126(5):781-3. PubMed ID: 24091414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
